The present study provides new insights into the adipocytokine, visfatin, and its ability to indirectly influence breast cancer progression through monocytic cell differentiation to TAMs, and trigger cytokine CXCL1 secretion to increase the malignant behavior of breast cancer. Here, CXCL1 is linked to breast carcinoma.